Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,208 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, not recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, not recruiting

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients

NCT06614699

Conditions
Atrophy, Body Weight, Colonic Diseases, +25 more
Locations
  • The Affiliated Yongchuan Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View Trial Details
Active, not recruiting

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

NCT04117945

Conditions
BRAF V600E Negative, Colonic Diseases, Colorectal Neoplasms, +21 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Active, not recruiting

Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)

NCT04515615

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer Stage III, +6 more
Locations
  • The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Lishui Central Hospital Lishui, Zhejiang, China
  • Taizhou Hospital Taizhou, Zhejiang, China
  • The Second Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
View Trial Details

Related conditions